Abstract
The RGD motif on the SARS-CoV-2 spike protein has been suggested to interact with RGD-binding integrins αVβ3 and α5β1 to enhance viral cell entry and alter downstream signaling cascades. The D405N mutation on the Omicron subvariant spike proteins, resulting in an RGN motif, has recently been shown to inhibit binding to integrin αVβ3. Deamidation of asparagines in protein ligand RGN motifs has been demonstrated to generate RGD and RGisoD motifs that permit binding to RGD-binding integrins. Two asparagines, N481 and N501, on the Wild-type spike receptor-binding domain have been previously shown to have deamidation half-lives of 16.5 and 123 days, respectively, which may occur during the viral life cycle. Deamidation of Omicron subvariant N405 may recover the ability to interact with RGD-binding integrins. Thus, herein, all-atom molecular dynamics simulations of the Wild-type and Omicron subvariant spike protein receptor-binding domains were conducted to investigate the potential for asparagines, the Omicron subvariant N405 in particular, to assume the optimized geometry for deamidation to occur. In summary, the Omicron subvariant N405 was primarily found to be stabilized in a state unfavourable for deamidation after hydrogen bonding with downstream E406. Nevertheless, a small number of RGD or RGisoD motifs on the Omicron subvariant spike proteins may restore the ability to interact with RGD-binding integrins. The simulations also provided structural clarification regarding the deamidation rates of Wild-type N481 and N501 and highlighted the utility of tertiary structure dynamics information in predicting asparagine deamidation. Further work is needed to characterize the effects of deamidation on spike-integrin interactions.
Keywords: SARS-CoV-2, Spike protein, Omicron BA.2, Omicron BA.5, Deamidation, RGD motif
1. Introduction
Numerous variants of the Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (e.g. Delta (B.1.617.2), Omicron (BA.1)) have arisen since the initial outbreak [1]. Among the recently evolved substrains, the aspartate of the putative integrin-binding RGD motif (Wild-type (WT) residues 403–405) on the spike protein receptor-binding domain (RBD) [[2], [3], [4], [5], [6]] has been mutated to an asparagine in the Omicron BA.2, BA.4, BA.5, and most recently discovered XBB.1.5 variants (labelled herein as O’), thus coding for an RGN motif instead of RGD (Fig. 1 A–C) [7]. Although the SARS-CoV-2 spike protein has been demonstrated to primarily interact with integrins αVβ3 [8] and α5β1 [9], which are RGD-binding integrins, the D405N variant has recently been shown to inhibit binding to integrin αvβ3 [10].
Fig. 1.
Deamidation potential of WT N481 and N501 and O′ N405 and N481.
A sequence alignment and phylogenetic tree of the WT, Delta, and Omicron substrain spike protein residues 396–412 (WT numbering) is shown (A). A representative SARS-CoV-2 virion (B) is depicted with a zoomed-in trimeric spike protein (C). The WT (cyan) and O’ (magenta) spike RBDs are portrayed (D) with a closer image of the D405 N mutation (E). The mechanism of asparagine deamidation is drawn (F).
Asparagine residues in RGN/NGR motifs have been discovered to undergo spontaneous deamidation through formation of a succinimide intermediate and subsequent hydrolysis to generate isoDGR motifs (Fig. 1D) that may also interact with RGD-binding integrins, such as αvβ3 [11,12]. Two solvent-exposed asparagine residues on the Wild-type spike protein receptor-binding domain (RBD), N481 and N501, have been experimentally determined to have deamidation half-life rates of 16.5 and 123 days, respectively [13]. Thus, deamidation of the D405N mutation may restore the ability of the spike protein to interact with RGD-binding integrins. Although molecular dynamics simulations have been previously utilized to detect changes in structural conformations that permit deamidation of asparagine residues, no study has yet investigated such tertiary structural effects on coronavirus spike proteins [14].
Thus, herein, the conformations of asparagine residues, particularly D405N, in the WT and O′ RBDs were analyzed to predict the structural potential for succinimide formation. Hydrogen bonding with downstream E406 was found to stabilize the O′ N405 residue away from the neighboring backbone nitrogen atom, suggesting that the N405 is unlikely to rapidly undergo deamidation. Nevertheless, even low half-life rates may result in a small number of deamidated sites per virion, thus potentially restoring the ability to interact with RGD-binding integrins. The experimentally-determined deamidation rates of asparagines on the WT RBD were further explained and supported by the data, and the impact of tertiary structure dynamics on additional asparagine residues on the WT and O’ spike RBDs was clarified. Additional structural validation is necessary to better understand deamidation rates on coronavirus spike proteins and potential changes in interactions with integrins.
2. Results
Sequence-based calculations using NGOME-Lite [15] suggest deamidation half-lives of the O′ N405 and N481 residues at 23.7 and 29.3 days, respectively. These results, however, should be taken as rough estimates since the WT N481 and N501 residues were predicted to have half-lives of 27.0 and 20.2 days, respectively, and were experimentally verified at 16.5 and 123 days, respectively, at 37 °C [13]. Thus, initial sequence-based predictions indicate that the O’ N405 may be deamidated during a time relevant for infection.
To examine the structural potential for deamidation of the asparagine residues, molecular dynamics simulations were used to determine changes in residue geometry that may permit succinimide formation [[16], [17], [18]]. Dihedral phi and psi angles between 40-60° and 35–50°, respectively, have been suggested to be predictive of succinimide formation, while residue flexibility and solvency have been debated regarding their effects on predicting deamidation [19,20]. The WT spike RGD motif has been previously suggested to be solvent accessible [21]. The WT spike RBD (PDB: 6m0j) N481 and N501 residues were analyzed alongside the O’ spike RBD (PDB: 7zxu) N405 and N481 residues as controls and to compare with published experimental data [13].
Three replicates of 1 μs-long all-atom molecular dynamics simulations were conducted for both the WT and O′ RBDs. The root mean square deviation (RMSD) values were, first, calculated to establish the time of convergence of the simulations (Fig. 2 A and B). All runs, with the exception of the third WT run, converged after 250 ns. Subsequently, the root mean square flexibility (RMSF) for each residue in the RBDs was assessed. The runs reported similar RMSF values with the exception of the third simulation WT RBD residues 440–450 and residues near the C- and N-terminal residues. Since the RMSF calculated for all residues except 440–450 during the third WT simulation were consistent with the other WT two runs, the data from all six productions were included (Fig. 2C and D). The WT and O′ N481 residues were found to be in highly flexible regions with average RMSF values of 3.5 ± 0.54 and 3.80 ± 0.18 Å, respectively, while both WT N501 and O′ N405 were discovered to be largely inflexible with RMSD values of 1.19 ± 0.25 and 0.88 ± 0.01 Å, respectively. These data suggest that the WT and O′ N481 residues may more likely assume the optimal geometries for deamidation, while the WT N501 and O’ N405 may only undergo rapid deamidation if naturally found in the correct conformation.
Fig. 2.
Rmsd and rmsf of the WT and O′ RBDs.
The production RMSD values are reported for the WT (A) and O’ (B) RBDs. The RMSF values for residues in the WT (C) and O’ (D) are shown with dashed red lines at residues N481 and N501 for the WT RBD and N405 and N481 for the O’ RBD.
The dihedral phi and psi angles of the productions were calculated, although only the dihedral psi angles were found to be indicative of the geometries conducive to succinimide formation when compared with experimentally-determined deamidation. Thus, the dihedral psi angles were used as a measure for deamidation potential. The WT and O′ N481 residues were found to adopt the preferred geometry for, on average, 9.4 ± 8.34 and 56.31 ± 35.95 ns, respectively (Fig. 3 B and C and 3K-L, respectively; Table 1 ). The WT N501 residue was not captured in the optimal state at any time during the simulation replicates (Fig. 3E and F). Visualization of the simulations reveal that the WT and O’ N481 residues are facing outwards in a flexible region with minor steric constraints on adoption of the preferred conformation (Fig. 3A and J, respectively). Inspection of the N501 residue revealed that the side chain amine may form hydrogen bonds with the backbone carbonyl of Y505, thus stabilizing the side chain group away from the N+1 amine necessary for deamidation (Fig. 3D). The WT results reflect the conclusions by Lorenzo et al. that the WT N481 may undergo deamidation during the viral life cycle while N501 most likely does not and such deamidation has no particular advantageous role – which is further evident in the N501Y mutation [22]. These data also highlight the predictive capability of structural dynamics for better understanding asparagine deamidation potential.
Fig. 3.
Backbone geometries of WT N481 and N501 and O′ N405 and N481.
The WT N481 (A) and N501 (D) and O′ N405 (G) and N481 (J) residues are depicted in cyan and magenta, respectively. Predicted hydrogen bonding between WT N501 and Y505 (D) and O′ N405 and E406 (G) are displayed with dashed yellow lines and the distance between atoms noted in angstroms. The time course of changes in WT N481 and N501 and O′ N405 and N481 dihedral phi angles (B, E, H, K, respectively) and dihedral psi angles (C, F, I, L, respectively) are shown with dashed red lines at 35° and 50°. Of note, the y-axis of the plot depicting the dihedral psi angle time course of O’ N405 (I) is shown from −50° to 50° to highlight the events in which the backbone is found in the optimal geometry for deamidation.
Table 1.
Durations that RBD asparagines were found in optimal geometries for succinimide formation.
| WT |
O’ |
O’/WT | |||
|---|---|---|---|---|---|
| AA | Time (ns) | SD | Time (ns) | SD | |
| N405 | – | – | 0.027 | 0.0058 | – |
| N417 | – | – | 0.015 | 0.0071a | – |
| N437 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| N439 | 1.63 | 1.06a | 0.42 | 0.34 | 0.26 |
| N440 | 15.56 | 26.08 | – | – | – |
| N448 | 0.27 | 0.43 | 0.39 | 0.21a | 1.44 |
| N450 | 7.13 | 12.12 | 2.60 | 4.38 | 0.37 |
| N460 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| N477 | – | – | 17.73 | 4.05 | – |
| N481 | 9.40 | 8.34 | 56.31 | 35.95 | 5.99 |
| N487 | 26.56 | 27.05 | 44.92 | 63.66 | 1.69 |
| N501 | 0.00 | 0.00 | – | – | – |
Only two simulations of the three were found to produce the data in the column to the left.
Interestingly, the O′ N405 residue was found to be in the state that undergoes succinimide formation during the first 50–250 ns of the simulations and, subsequently, assumed a state that primarily did not allow such conformations for the remainder of the simulations – only 0.027 ± 0.0058 ns (Fig. 3H and I). Visualization of the simulations revealed that the carboxylic group of the downstream E406 eventually forms a hydrogen bond with the amine of the N405 residue, thus stabilizing the group outside of the permitted range for deamidation (Fig. 3G). The starting conformations are likely to be artefacts of the crystallization process [23]. A simulation of the E406A O′ mutation was, thus, run to test for the effect of this putative hydrogen bonding. The resulting flexibility of O′ N405 was slightly increased to 0.95 Å, which reflects a loss of stabilization due to hydrogen bonding. The mutation was found to increase the time for which N405 side group was at an the optimal psi angle to 0.88 ns. These data suggest that both hydrogen bonding with E406 and backbone constraints hinder N405 from structurally adopting the preferred deamidation geometries (Fig. 4 A–C). The pKa of E406 is predicted to be 3.21 and 3.3 using the DelPhiPKa [24] and H++ 3.0 [25] web servers, respectively, which are below physiologic and lysosome pH. Thus, potential protonation of E406 is not likely to occur or affect hydrogen binding with N405. These results suggest that the O′ N405 does not rapidly undergo deamidation, as in the case of WT and O’ N481, and its half-life rate more likely resembles that of the WT N501Y residue.
Fig. 4.
Deamidation potential of other asparagine residues on the WT and O′ RBDs.
The E406A mutant O′ N405 residue is depicted (A). The time course of changes in N405 dihedral phi (B) and psi (C) for the E406A mutant are shown. The WT (cyan) and O’ (magenta) spike protein RBDs are aligned with all asparagines (yellow) near the receptor-binding motif are displayed (D). A zoomed-in image of the hydrogen bonding (represented as yellow dashed lines with the inter-atomic distances in angstroms) between WT Y449 and Q498 and O’ V445 and R498 are shown.
The geometries of all other surface-exposed asparagines near the receptor-binding motif were measured to note additional evolutionary differences in deamidation between the WT and O′ RBDs (Fig. 4D) [26]. Comparing WT and O′ RBD asparagine content not discussed above, one mutation, N440K, removed and two mutations, K417N and S477N, added an asparagine to the spike RBD, leading to one additional asparagine in the O′ spike RBD. The reported dihedral psi angles revealed that the WT N440 and WT/O′ N439, N450, and N487 residues are likely to undergo deamidation while the WT/O′ N437, N448, and N460 and O′ N417 may not (Table 1). Most strikingly, although N450 was largely found to be able to adopt the preferred geometry in the WT RBD, it was diminished in the O′ RBD. Inspection of the WT/O′ N450 and surrounding residues revealed that the Q498R mutation may affect the conformation of the backbone of N450 (Fig. 4E). Hydrogen bonding between WT Q498 and Y449 pulls the backbone of the N450 residue further from potential steric clashes with the Y451 residue. The O′ R498 side chain hydrogen bonds, instead, with the backbone carbonyl of V445 and permits the backbone of N450 to pack closer to the RBD, thus imposing clashes with Y451 with respect to the geometry required for succinimide formation. Furthermore, hydrogen bonding between the sidechain amide of WT N448 and the backbone carbonyl of D442 was found to stabilize the amide away from the neighboring backbone amine. This hydrogen bonding was also disrupted by the backbone of N450 backbone moving inwards as a result of the Q498R mutation, thus increasing the potential for the O’ N448 to be deamidated. The discovery of such putative local and long-range interactions further emphasizes the effect of tertiary structure on deamidation potential.
3. Discussion
In summary, structural investigations suggest that the N405 does not undergo rapid deamidation. These data also provide mechanistic details at atomic resolution into the experimentally-determined deamidation rates of asparagines on the WT RBD. Notably, two asparagines, N481 and N501, are positioned directly upstream of a glycine, which is thought to be predictive of deamidation potential, although only N481 was found to rapidly deamidate [27]. The tertiary positioning of downstream charged residues, such as glutamate in the context of O′ N405, has been previously found to impact deamidation potential [28]. For instance, a human interleukin 1α asparagine is directly upstream of an aspartate, but the aspartate is pointing inwards towards the core of the protein and away from the asparagine, thus having no effect [29]. Additionally, presence in an alpha helix, such as in the case of O’ N405, has been found to impede deamidation, which is further supported by these data [14]. These findings and those in this study further highlight the importance of inspecting tertiary structure and its dynamics to understand and predict asparagine deamidation potential. Furthermore, rapid deamidation of residues found in solvent-exposed epitopes, such as the N477, may provide an evolutionary benefit through antibody evasion [13]. Notably, other factors, such as pH and solvent catalysts, may have an impact on deamidation rates and, thus, should be investigated further. Additional work is necessary to characterize the extent to which coronavirus spike proteins undergo deamidation and its effect on protein-protein interactions.
Nevertheless, it should be noted that even a small deamidation rate per receptor-binding domain, may not necessarily imply functional irrelevance. This is because there are approximately 40 spike proteins per virion, with three receptor-binding domains per spike protein, i.e., about 120 receptor-binding domains per virion [30]. Assuming that the conversion of the RGN to an RGD or RGisoD sequence follows a first order exponential equation, the fraction of receptor-binding domains that contains an RGN motif after time t (F(RGN)t), is given by: F(RGN)t = 2-(t/t1/2), where t1/2 is the half-life for deamidation. Or, equivalently, the fraction of RGN motifs converted to RGD/RGisoD after time t (F(RGisoD)t) is given by: F(RGisoD)t = 1-2-(t/t1/2). Assuming that the deamidation of RGN to RGD/RGisoD occurs independently and stochastically and that this individual probability per unit time is low (given that the molecular dynamics simulations suggest a long half-life), the conversion can be modelled by Poisson statistics. Hence, the fraction of viruses with at least one receptor-binding domain that undergo deamidation at this site after time t is: 1 - e(−120∗F(RGisoD)t). At time = t1/2, by definition, only half of the receptor-binding domains have deamidated at this site. But the fraction of viruses that has at least one receptor-binding domain with an RGD/RGisoD sequence is: 1 - e−60, which is essentially 1. SARS-CoV-2 has been found to be stable on several surfaces, such as plastic, glass, and latex gloves, for at least seven days [31]. Calculating the longest reported half-life of 123 days, based on the findings by Lorenzo et al., for seven days, then:
F(RGisoD)t = 1-2-(t/t1/2) = 1-2-(7/123) ∼ 0.0039. Thus, after seven days, the fraction of viruses that are predicted to have at least one RGD/RGisoD is: 1- e(−7∗120) ∼ 0.99 (Table 2 ). Even after one day, approximately half of a given sample population of viruses will have at least one deamidated N405.
Table 2.
Estimated probability of at least one SARS-CoV-2 Omicron subvariant virion N405 to undergo deamidation (assuming a t1/2 of 123 days (see text).
| Days | F(RGisoD)t | Probability |
|---|---|---|
| 0 | 0.00000 | 0.000 |
| 0.1 | 0.00056 | 0.065 |
| 0.2 | 0.00113 | 0.126 |
| 0.3 | 0.00169 | 0.183 |
| 0.4 | 0.00225 | 0.237 |
| 0.5 | 0.00281 | 0.287 |
| 0.6 | 0.00338 | 0.333 |
| 0.7 | 0.00394 | 0.377 |
| 0.8 | 0.00450 | 0.417 |
| 0.9 | 0.00506 | 0.455 |
| 1 | 0.00562 | 0.491 |
| 2 | 0.01121 | 0.739 |
| 3 | 0.01676 | 0.866 |
| 4 | 0.02229 | 0.931 |
| 5 | 0.02778 | 0.964 |
| 6 | 0.03325 | 0.981 |
| 7 | 0.03868 | 0.990 |
Thus, even the potential slow deamidation of O’ N405 may generate a mixture of RGN, RGisoD, and RGD motifs on the virion spike proteins that may restore the ability to bind with integrins. Further work is needed to characterize the capacity for deamidated SARS-CoV-2 subvariant spike proteins to interact with RGD-binding integrins. The investigation of potential non-RGD-based interactions between integrins and SARS-CoV-2 subvariant spike proteins remains warranted [21,32]. These findings re-emphasize the relevance of integrin-based therapies for SARS-CoV-2 and other viral infections [9,33,34]. Monitoring of mutations and their potential impacts on protein-protein interactions may reveal novel insights into viral pathogenesis and tropism [35].
4. Methods
4.1. Sequence accessions and analyses
The Wild-type (NCBI Accession: P0DTC2) and representative Delta (QUD52764), Omicron BA.1 (UFO69279), Omicron BA.2 (UJP23605), BA.4 (UPP14409), BA.5 (UOZ45804), XBB.1.5 (WBG51102) variant spike protein sequences were accessed from NCBI and ViralZone [36,37]. The sequences were aligned using MAFFT [38], and a phylogenetic tree was generated with FastTree 2 [39] and visualized using iTOL [40]. Sequence-based predictions of deamidation half-lives were calculated using NGOME-Lite [15].
4.2. Protein structure models, modelling, and analyses
The Wild-type (PDB: 6moj [41]) and BA.4/BA5 Omicron (PDB: 7zxu [42]) spike protein RBD models were retrieved from PDB [43]. The E406A mutant RBD was made using MODELLER [44] with the BA.4/BA5 Omicron (PDB: 7zxu) model as a template. The DelPhiPKa [24] and H++ 3.0 [25] web servers were used with default values to predict the pKa of the O’ E406 residue.
4.3. Molecular dynamics simulations and analyses
All-atom molecular dynamics simulations were prepared and run using GROMACS 2021.3 [45] using the University of Cambridge High Performance Computing resources. Periodic boundary conditions were established in a cubic box with the smallest distance between the protein and box edge set at 2 Å. All systems were solvated in 150 mM NaCl at a zero net charge using the TIP3P model [46] and were run at 300 K [47]. The Particle-mesh Ewald method was used to calculate long-range electrostatic interactions, and the cutoff for Coulomb interactions and van der Waals interactions were set to 10 Å [48]. Following a 100 ps steepest descent minimization, all systems were subjected to an NVT equilibration ensemble with temperature coupling using velocity rescaling [49] for 100 ps and an NPT equilibration ensemble with pressure coupling using the Parrinello-Rahman method [50] for 100 ps. All simulations were run using the OPLS-AA/L all-atom force field with 2 fs time steps [51]. Triplicate productions of 1 μs each were run for both the WT and O′ RBDs, and one 1 μs production was run for the O’ E406A mutant model. VMD was used to visualize snapshot structures from the productions [52]. The last 250 ns – after convergence of the simulations as evidenced by the RMSD values – of the runs were analyzed to account for the influence of crystallization on protein structure [23,53]. The RMSD, RMSF, and dihedral phi and psi angles were extracted from the simulation trajectories using the gmx rms, gmx rmsf, gmx rama GROMACS modules, respectively [54]. The data were plotted using R version 3.6.3.
Data availability
Data reported in this manuscript is available upon request.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
We greatly thank the team at the University of Cambridge High Performance Computing Centre. CAB is grateful for the support provided by Antibiotic Research UK (ANTSRG 01/2019-PHZJ/687). SCV and TLB thank the American Leprosy Missions for their support (Grant No: G88726).
References
- 1.Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Kosakovsky Pond S.L., Fera D., Shafer R.W. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat. Rev. Genet. 2021;22:757–773. doi: 10.1038/s41576-021-00408-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Nader D., Kerrigan S.W. Molecular cross-talk between integrins and cadherins leads to a loss of vascular barrier integrity during SARS-CoV-2 infection. Viruses. 2022;14:891. doi: 10.3390/v14050891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gao S., Lu Y., Luan J., Zhang L. Low incidence rate of diarrhoea in COVID-19 patients is due to integrin. J. Infect. 2021;83:496–522. doi: 10.1016/j.jinf.2021.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Robles J.P., Zamora M., Adan-Castro E., Siqueiros-Marquez L., Martinez de la Escalera G., Clapp C. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. J. Biol. Chem. 2022;298 doi: 10.1016/j.jbc.2022.101695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Liu J., Lu F., Chen Y., Plow E., Qin J. Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2. J. Biol. Chem. 2022;298 doi: 10.1016/j.jbc.2022.101710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Tresoldi I., Sangiuolo C.F., Manzari V., Modesti A. SARS-COV-2 and infectivity: possible increase in infectivity associated to integrin motif expression. J. Med. Virol. 2020;92:1741–1742. doi: 10.1002/jmv.25831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chatterjee S., Bhattacharya M., Nag S., Dhama K., Chakraborty C. A detailed overview of SARS-CoV-2 Omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies. Viruses. 2023;15:167. doi: 10.3390/v15010167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nader D., Fletcher N., Curley G.F., Kerrigan S.W. SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19. PLoS One. 2021;16 doi: 10.1371/journal.pone.0253347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y., Kolls J.K., Bix G.J. The integrin binding peptide, ATN-161, as a novel therapy for SARS-CoV-2 infection. JACC (J. Am. Coll. Cardiol.): Basic to Translational Science. 2021;6:1–8. doi: 10.1016/j.jacbts.2020.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bugatti A., Filippini F., Messali S., Giovanetti M., Ravelli C., Zani A., Ciccozzi M., Caruso A., Caccuri F. The D405N mutation in the spike protein of SARS-CoV-2 Omicron BA.5 inhibits spike/integrins interaction and viral infection of human lung microvascular endothelial cells. Viruses. 2023;15:332. doi: 10.3390/v15020332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Curnis F., Longhi R., Crippa L., Cattaneo A., Dondossola E., Bachi A., Corti A. Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J. Biol. Chem. 2006;281:36466–36476. doi: 10.1074/jbc.M604812200. [DOI] [PubMed] [Google Scholar]
- 12.Sacchi A., Gasparri A.M., Monieri M., Anderluzzi G., Colombo B., Gori A., Corti A., Curnis F. Nanogold functionalized with lipoamide-isoDGR: a simple, robust and versatile nanosystem for αvβ3-integrin targeting. Front. Chem. 2021;9 doi: 10.3389/fchem.2021.690357. https://www.frontiersin.org/articles/10.3389/fchem.2021.690357 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lorenzo R., Defelipe L.A., Aliperti L., Niebling S., Custódio T.F., Löw C., Schwarz J.J., Remans K., Craig P.O., Otero L.H., Klinke S., García-Alai M., Sánchez I.E., Alonso L.G. Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif. J. Biol. Chem. 2021;297 doi: 10.1016/j.jbc.2021.101175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Robinson N.E., Robinson A.B. Prediction of protein deamidation rates from primary and three-dimensional structure. Proc. Natl. Acad. Sci. USA. 2001;98:4367–4372. doi: 10.1073/pnas.071066498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lorenzo J.R., Leonetti C.O., Alonso L.G., Sánchez I.E. NGOME-Lite: proteome-wide prediction of spontaneous protein deamidation highlights differences between taxa. Methods. 2022;200:15–22. doi: 10.1016/j.ymeth.2020.11.001. [DOI] [PubMed] [Google Scholar]
- 16.Jia L., Sun Y. In: Computer-Aided Antibody Design. Tsumoto K., Kuroda D., editors. Springer US; New York, NY: 2023. In silico prediction method for protein asparagine deamidation; pp. 199–217. [DOI] [Google Scholar]
- 17.Jia L., Sun Y. Protein asparagine deamidation prediction based on structures with machine learning methods. PLoS One. 2017;12 doi: 10.1371/journal.pone.0181347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Xiang T.-X., Anderson B.D. A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone) J. Pharmaceut. Sci. 2004;93:855–876. doi: 10.1002/jps.20004. [DOI] [PubMed] [Google Scholar]
- 19.Kato K., Nakayoshi T., Kurimoto E., Oda A. Mechanisms of deamidation of asparagine residues and effects of main-chain conformation on activation energy. Int. J. Mol. Sci. 2020;21:7035. doi: 10.3390/ijms21197035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yan Q., Huang M., Lewis M.J., Hu P. Structure based prediction of asparagine deamidation propensity in monoclonal antibodies. mAbs. 2018;10:901–912. doi: 10.1080/19420862.2018.1478646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Beaudoin C.A., Hamaia S.W., Huang C.L.-H., Blundell T.L., Jackson A.P. Can the SARS-CoV-2 spike protein bind integrins independent of the RGD sequence? Front. Cell. Infect. Microbiol. 2021:11. doi: 10.3389/fcimb.2021.765300. https://www.frontiersin.org/articles/10.3389/fcimb.2021.765300 January 10, 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tian F., Tong B., Sun L., Shi S., Zheng B., Wang Z., Dong X., Zheng P. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife. 2021;10 doi: 10.7554/eLife.69091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Axelsen P.H., Harel M., Silman I., Sussman J.L. Structure and dynamics of the active site gorge of acetylcholinesterase: synergistic use of molecular dynamics simulation and X-ray crystallography. Protein Sci. 1994;3:188–197. doi: 10.1002/pro.5560030204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang L., Li L., Alexov E. pKa predictions for proteins, RNAs, and DNAs with the Gaussian dielectric function using DelPhi pKa. Proteins. 2015;83:2186–2197. doi: 10.1002/prot.24935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Anandakrishnan R., Aguilar B., Onufriev A.V. H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 2012;40:W537–W541. doi: 10.1093/nar/gks375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Beaudoin C.A., Jamasb A.R., Alsulami A.F., Copoiu L., van Tonder A.J., Hala S., Bannerman B.P., Thomas S.E., Vedithi S.C., Torres P.H.M., Blundell T.L. Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses. Comput. Struct. Biotechnol. J. 2021;19:3938–3953. doi: 10.1016/j.csbj.2021.06.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Phillips J.J., Buchanan A., Andrews J., Chodorge M., Sridharan S., Mitchell L., Burmeister N., Kippen A.D., Vaughan T.J., Higazi D.R., Lowe D. Rate of asparagine deamidation in a monoclonal antibody correlating with hydrogen exchange rate at adjacent downstream residues. Anal. Chem. 2017;89:2361–2368. doi: 10.1021/acs.analchem.6b04158. [DOI] [PubMed] [Google Scholar]
- 28.Gamage C.L.D., Hageman T.S., Weis D.D. Rapid prediction of deamidation rates of proteins to assess their long-term stability using hydrogen exchange–mass spectrometry. J. Pharmaceut. Sci. 2019;108:1964–1972. doi: 10.1016/j.xphs.2019.01.019. [DOI] [PubMed] [Google Scholar]
- 29.Graves B.J., Hatada M.H., Hendrickson W.A., Miller J.K., Madison V.S., Satow Y. Structure of interleukin 1 .alpha. at 2.7- ANG. resolution, Biochemistry. 1990;29:2679–2684. doi: 10.1021/bi00463a009. [DOI] [PubMed] [Google Scholar]
- 30.Turoňová B., Sikora M., Schürmann C., Hagen W.J.H., Welsch S., Blanc F.E.C., von Bülow S., Gecht M., Bagola K., Hörner C., van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S., Schwarz A., Covino R., Mühlebach M.D., Hummer G., Krijnse Locker J., Beck M. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. Science. 2020;370:203–208. doi: 10.1126/science.abd5223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Liu Y., Li T., Deng Y., Liu S., Zhang D., Li H., Wang X., Jia L., Han J., Bei Z., Li L., Li J. Stability of SARS-CoV-2 on environmental surfaces and in human excreta. J. Hosp. Infect. 2021;107:105–107. doi: 10.1016/j.jhin.2020.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Othman H., Messaoud H.B., Khamessi O., Ben-Mabrouk H., Ghedira K., Bharuthram A., Treurnicht F., Achilonu I., Sayed Y., Srairi-Abid N. SARS-CoV-2 spike protein unlikely to bind to integrins via the arg-gly-asp (RGD) motif of the receptor binding domain: evidence from structural analysis and microscale accelerated molecular dynamics. Front. Mol. Biosci. 2022;9 doi: 10.3389/fmolb.2022.834857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gressett T.E., Nader D., Robles J.P., Buranda T., Kerrigan S.W., Bix G. Integrins as therapeutic targets for SARS-CoV-2. Front. Cell. Infect. Microbiol. 2022;12 doi: 10.3389/fcimb.2022.892323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Amruta N., Engler-Chiurazzi E.B., Murray-Brown I.C., Gressett T.E., Biose I.J., Chastain W.H., Befeler J.B., Bix G. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice. Life Sci. 2021;284 doi: 10.1016/j.lfs.2021.119881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Alipoor S.D., Mirsaeidi M. SARS-CoV-2 cell entry beyond the ACE2 receptor. Mol. Biol. Rep. 2022:1–13. doi: 10.1007/s11033-022-07700-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sayers E.W., Bolton E.E., Brister J.R., Canese K., Chan J., Comeau D.C., Connor R., Funk K., Kelly C., Kim S., Madej T., Marchler-Bauer A., Lanczycki C., Lathrop S., Lu Z., Thibaud-Nissen F., Murphy T., Phan L., Skripchenko Y., Tse T., Wang J., Williams R., Trawick B.W., Pruitt K.D., Sherry S.T. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2022;50:D20–D26. doi: 10.1093/nar/gkab1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hulo C., de Castro E., Masson P., Bougueleret L., Bairoch A., Xenarios I., Le Mercier P., ViralZone A knowledge resource to understand virus diversity. Nucleic Acids Res. 2011;39:D576–D582. doi: 10.1093/nar/gkq901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Katoh K., Standley D.M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 2013;30:772–780. doi: 10.1093/molbev/mst010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Price M.N., Dehal P.S., Arkin A.P. FastTree 2 – approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5 doi: 10.1371/journal.pone.0009490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Letunic I., Bork P. Interactive Tree of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49:W293. doi: 10.1093/nar/gkab301. –W296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–220. doi: 10.1038/s41586-020-2180-5. [DOI] [PubMed] [Google Scholar]
- 42.Tuekprakhon A., Nutalai R., Dijokaite-Guraliuc A., Zhou D., Ginn H.M., Selvaraj M., Liu C., Mentzer A.J., Supasa P., Duyvesteyn H.M.E., Das R., Skelly D., Ritter T.G., Amini A., Bibi S., Adele S., Johnson S.A., Constantinides B., Webster H., Temperton N., Klenerman P., Barnes E., Dunachie S.J., Crook D., Pollard A.J., Lambe T., Goulder P., Paterson N.G., Williams M.A., Hall D.R., Conlon C., Deeks A., Frater J., Frending L., Gardiner S., Jämsén A., Jeffery K., Malone T., Phillips E., Rothwell L., Stafford L., Fry E.E., Huo J., Mongkolsapaya J., Ren J., Stuart D.I., Screaton G.R. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185 doi: 10.1016/j.cell.2022.06.005. 2422-2433.e13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Burley S.K., Bhikadiya C., Bi C., Bittrich S., Chao H., Chen L., Craig P.A., Crichlow G.V., Dalenberg K., Duarte J.M., Dutta S., Fayazi M., Feng Z., Flatt J.W., Ganesan S., Ghosh S., Goodsell D.S., Green R.K., Guranovic V., Henry J., Hudson B.P., Khokhriakov I., Lawson C.L., Liang Y., Lowe R., Peisach E., Persikova I., Piehl D.W., Rose Y., Sali A., Segura J., Sekharan M., Shao C., Vallat B., Voigt M., Webb B., Westbrook J.D., Whetstone S., Young J.Y., Zalevsky A., Zardecki C. RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic Acids Res. 2023;51:D488–D508. doi: 10.1093/nar/gkac1077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
- 45.Abraham M.J., Murtola T., Schulz R., Páll S., Smith J.C., Hess B., Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1–2:19–25. doi: 10.1016/j.softx.2015.06.001. [DOI] [Google Scholar]
- 46.Joung I.S., Cheatham T.E.I. Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J. Phys. Chem. B. 2008;112:9020–9041. doi: 10.1021/jp8001614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bondi A. van der Waals volumes and radii. J. Phys. Chem. 1964;68:441–451. doi: 10.1021/j100785a001. [DOI] [Google Scholar]
- 48.Darden T., York D., Pedersen L. Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089–10092. doi: 10.1063/1.464397. [DOI] [Google Scholar]
- 49.Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007;126 doi: 10.1063/1.2408420. [DOI] [PubMed] [Google Scholar]
- 50.Parrinello M., Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 1981;52:7182–7190. doi: 10.1063/1.328693. [DOI] [Google Scholar]
- 51.Kaminski G.A., Friesner R.A., Tirado-Rives J., Jorgensen W.L. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J. Phys. Chem. B. 2001;105:6474–6487. doi: 10.1021/jp003919d. [DOI] [Google Scholar]
- 52.Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 1996;14(33–38):27–28. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
- 53.Kossiakoff A.A., Randal M., Guenot J., Eignebrot C. Variability of conformations at crystal contacts in BPTI represent true low-energy structures: correspondence among lattice packing and molecular dynamics structures. Proteins: Struct., Funct., Bioinf. 1992;14:65–74. doi: 10.1002/prot.340140108. [DOI] [PubMed] [Google Scholar]
- 54.Pronk S., Páll S., Schulz R., Larsson P., Bjelkmar P., Apostolov R., Shirts M.R., Smith J.C., Kasson P.M., van der Spoel D., Hess B., Lindahl E. Gromacs 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29:845–854. doi: 10.1093/bioinformatics/btt055. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data reported in this manuscript is available upon request.




